Major U.S. indices traded higher Monday, with Dow Jones Futures edging up 0.09% to 48,893, the S&P 500 advancing 0.12% to 6,860.50 and the Nasdaq climbing 0.18% to 24,808.25.
These are the top stocks that gained the attention of retail traders and investors through the day.
Hims & Hers Health Inc. (NYSE:HIMS)
Hims & Hers Health shares fell 0.77% to close at $15.51, with an intraday high of $15.80 and a low of $15.16. The stock’s 52-week range is $15.16 to $70.43. In the after-hours trading, the stock fell 8.45% to $14.20.
Hims & Hers Health reported fourth-quarter revenue of $617.82 million, up 28% year over year but below estimates of $619.22 million, while earnings came in at $0.08 per share, topping expectations of $0.03. Subscribers surpassed 2.5 million, gross margin narrowed to 72% from 77% a year earlier, operating cash flow totaled $61.3 million, and free cash flow was negative $2.6 million, with cash holdings of $228.62 million.
The company guided first-quarter revenue of $600 million to $625 million, below estimates of $653.12 million, and projected full-year 2026 revenue of $2.7 billion to $2.9 billion, compared with expectations of $2.74 billion.
Novo Nordisk A/S (NYSE:NVO)
Novo Nordisk saw a significant drop of 16.43%, closing at $39.63. The stock hit an intraday high of $41.09 and a low of $39.34, marking a new 52-week low.
Novo Nordisk AS shares plunged more than 16% to a 52-week low, extending their one-month decline to 36%, after its REDEFINE 4 Phase 3 trial failed to meet the primary endpoint of non-inferiority against Eli Lilly and Company’s tirzepatide. In the 84-week study of 809 subjects, CagriSema showed 23.0% weight loss among adherent patients versus 25.5% for tirzepatide, and 20.2% versus 23.6% under the treatment-regimen estimand.
The setback was viewed by analysts as a worst-case outcome that weakened Novo Nordisk’s competitive position in the obesity market, with further data from REDEFINE 11 expected in 2027 and a higher-dose trial slated to begin in late 2026.
PayPal Holdings Inc. (NASDAQ:PYPL)
PayPal’s stock rose 5.76%, ending the day at $44.05. The stock reached a high of $45.69 and a low of $40.52, with a 52-week range of $38.46 to $79.50.
PayPal Holdings shares rose more than 5% after reports that potential buyers approached the company following a more than 40% decline over the past year and a 20% post-earnings sell-off that erased nearly $10 billion in market value. At least one large competitor was said to be evaluating a bid for the entire company, while others explored specific assets, though discussions remained preliminary.
The takeover interest emerged amid leadership upheaval, including a CEO change effective March 1, 2026, slowing Branded Checkout growth to 1% from 5%–6% in prior quarters, and a reduced fiscal 2026 outlook projecting a single-digit earnings decline to slight growth.
Uber Technologies Inc. (NYSE:UBER)
Uber’s shares declined by 4.25%, closing at $70.72. The stock’s intraday high was $73.11, with a low of $70.15, and a 52-week range of $60.63 to $101.99.
Uber Technologies Inc. launched Uber Autonomous Solutions, a new initiative focused on infrastructure, user experience and fleet operations to accelerate the commercialization of self-driving vehicles, alongside plans to invest over $100 million in charging infrastructure for its autonomous fleet. The company partnered with Avride, Nuro, Wayve and WeRide to scale deployment globally.
Shares fell about 4.5% to $73.15, with investors also looking ahead to the May 6, 2026, earnings report, where revenue was estimated at $13.30 billion, up from $11.53 billion a year earlier, and earnings were projected at $0.71 per share, down from $0.83 year over year.
BWX Technologies Inc. (NYSE:BWXT)
BWX Technologies experienced a 3.90% drop, closing at $198.38. The stock’s intraday high and low were $206 and $197.62, respectively, with a 52-week range of $84.21 to $220.57. In extended trading, the stock shot up over 9% to $216.40.
BWX Technologies Inc. reported fourth-quarter EPS of $1.08, beating estimates of $0.89 by 21.35%, while revenue increased $139.57 million from a year earlier. In the prior quarter, the company had topped EPS expectations by $0.15.
For fiscal 2026, BWX Technologies guided earnings to a range of $4.55 to $4.70 per share.
Benzinga Edge Stock Rankings indicate HIMS stock has Growth in the 86th percentile and Value in the 12th percentile.
This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal
Photo Courtesy: Vintage Tone on Shutterstock.com
Recent Comments